# MDR Vivacit-E Elevated Study

> **NCT07150221** · — · ENROLLING_BY_INVITATION · sponsor: **Zimmer Biomet** · enrollment: 52 (estimated)

## Conditions studied

- Osteoarthritis (OA) of the Hip
- Avascular Necrosis of Bone of Hip
- Protrusio Acetabuli
- Traumatic Arthropathy-Hip
- Slipped Capital Femoral Epiphyses
- Fused Hip
- Fracture of Pelvis
- Diastrophic Variant

## Interventions

- **DEVICE:** Vivacit-E Elevated Liners

## Key facts

- **NCT ID:** NCT07150221
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-07
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07150221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07150221, "MDR Vivacit-E Elevated Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07150221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*